Monitoring via implanted blood pressure sensor in heart failure - G-BA is again examining the status of research

22.08.2023 18:08

There are new scientific findings regarding telemedical therapy control for patients with heart failure via a permanently implanted blood pressure sensor. The first results of the Dutch study MONITOR HF have recently been published, which the Federal Joint Committee (G-BA) will incorporate into its benefit assessment. He is therefore having the Institute for Efficiency and Quality in Health Care (IQWiG) once again determine the state of research. The last time IQWiG did this was as part of the potential assessment of this method.

Since the existing study situation has not yet been sufficient to be able to conclusively assess the benefits of the method, the PASSPORT-HF test study has been running since 2020 on behalf of the G-BA and co-financed by the manufacturer. The test study aims to answer the question of whether the therapy of patients with heart failure in stage NYHA III can be optimized if blood pressure is continuously measured and monitored using an implanted sensor in the pulmonary artery. As part of the commissioning of IQWiG, it will also be examined what possible effects the results of the MONITOR-HF study could have on the PASSPORT-HF study. IQWiG will present its research results on the state of research by February 2024.